<HTML><HEAD><META http-equiv="Content-type" content="text/html;charset=UTF-8"></HEAD><BODY><DIV><P><BR>               <BR>               <BR>               INDICATIONS AND USAGE<BR>               <BR>                  AROMASIN is indicated for adjuvant treatment of postmenopausal <BR>women with estrogen-receptor positive early breast cancer who have received two <BR>to three years of tamoxifen and are switched to AROMASIN for completion of a <BR>total of five consecutive years of adjuvant hormonal therapy.<BR>                  AROMASIN is indicated for the treatment of advanced breast cancer in <BR>postmenopausal women whose disease has progressed following tamoxifen therapy.<BR>               <BR>               <BR>            <BR>         </P></DIV></HTML>